Case

Age and Gender

Time

Dose

Pathology

sIL-2R

SUVmax

Lesions

(y)

(mo)

(mg/week)

(U/ml)

Nodal

Extranodal

1

57F

54

NA

MALT

894

3.6

0

1

2

74F

120

6

DLBCL

918

21.2

1

6

3

75F

63

8.75

Hodgkin

1942

10.6

2

1

4

69M

81

15

DLBCL

1170

31.3

0

1

5

71F

70

6

DLBCL

889

12.2

4

2

6

69F

59

8

Hodgkin

4911

14.8

10

1

7

72F

84

8

PTCL

1498

7.6

4

1

8

67F

25

8

Hodgkin

12653

11.8

9

1

9

64F

56

6

DLBCL

1041

4.2

0

1

10

75F

30

6

DLBCL

475

10.3

3

1

11

61M

18

12

DLBCL

2283

32.8

4

2